Study on Veterans Reveals Real-World Survival Outcomes for Targeted Therapies in Advanced Renal Cell Carcinoma
Findings underscore the limited generalizability of clinical trial results to patients in the real world.
Urologic Cancers
UROLOGIC CANCER ADVISOR
FEATURED CONTENT
-
-
FDA Proposal Threatens Transparency on Cancer Drug Safety and Efficacy
FDA documents have been a trove of information for researchers, leading to new insights about the safety and efficacy of a drug. An FDA proposal could end that. -
Everyone’s Conflicted: How Open Payments Did Little to Discourage Conflicts of Interest in Oncology
Since its inception, the Open Payments act does not appear to have prompted physicians to accept fewer payments from industry overall. -
The Disappointing Reality of Crowdfunding Cancer Care
If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity. -
Some Targeted Therapies May Miss the Mark
Ten different drugs continued to kill cancer cells even when their target proteins were removed.
UROLOGIC CANCERS NEWS
Long-Term Cancer Survivors Identify Ongoing Challenges Related to Ostomy Self-Management
High-Throughput Multichain Immune Repertoire Sequencing for Prediction of Treatment Response in Renal Cell Carcinoma
Machine-Based CT May Help Identify BAP1 Mutation Status in Clear Cell Renal Cell Carcinoma
Preoperative Pyuria Predicts Bladder Recurrence After UTUC Surgery
RCC With Isolated Lymph Node Metastases Has Poor Prognosis After Surgery
Want to read more?
Please login or register first to view this content.
Next post in General Oncology
